Private Money Keeps Hunt For E.T.'s Alive

(The Scientist, Vol:8, #10, May 16, 1994) Renamed Project Phoenix, for the mythical creature that rises anew from its own ashes, the world's largest, most comprehensive atempt to search for signs of intelligent life forms in other parts of the universe continues to function, despite being cut out of the federal budget last year. The effort--formerly under the aegis of the National Aeronautics and Space Administration (NASA) and call

Written byNeeraja Sankaran
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

(The Scientist, Vol:8, #10, May 16, 1994)

Renamed Project Phoenix, for the mythical creature that rises anew from its own ashes, the world's largest, most comprehensive atempt to search for signs of intelligent life forms in other parts of the universe continues to function, despite being cut out of the federal budget last year. The effort--formerly under the aegis of the National Aeronautics and Space Administration (NASA) and called "Project SETI" (Search for Extraterrestrial Intelligence)--will now be funded by a number of private sources, rather than through the money originally designated by NASA.

Even the principal faces on the project remain familiar, particularly that of John Billingham, who has joined the SETI Institute in Mountain View, Calif., as a distinguished senior scientist. The British-born physician--who in the early 1960s invented the liquid cooling garment that made moon walking possible--was the chief of SETI operations at NASA. He retired on April ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies